American Society of Hirudotherapy

Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report

Case report published in Cureus (2026)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportClinical TrialsVelasco-Bustamante J et al. · Cureus, 2026

Abstract

The reverse sural flap is a commonly used surgical option for soft-tissue defects of the distal leg, ankle, and heel in hospitals where microsurgical capabilities are limited. However, one of its most frequent complications is venous congestion, which can lead to partial or total flap necrosis if not promptly addressed. We present the case of a patient with a traumatic crush injury of the right ankle, reconstructed with a reverse-flow sural flap that subsequently developed venous congestion in the immediate postoperative period (<12 hours). A local subcutaneous enoxaparin protocol (low-molecular-weight heparin) was implemented as a salvage strategy. This intervention successfully reversed the clinical signs of venous congestion and preserved approximately 80% of the flap's viability. This report discusses the underlying pathophysiology, the applied protocol, previous evidence, and the clinical implications of this approach.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Summary

The reverse sural flap is a commonly used surgical option for soft-tissue defects of the distal leg, ankle, and heel in hospitals where microsurgical capabilities are limited.

Why This Matters for Hirudotherapy

This case report examined the management of acute venous congestion in a reverse-flow sural flap used to reconstruct a traumatic ankle crush injury, employing a local subcutaneous enoxaparin (low-molecular-weight heparin) protocol as a salvage intervention that reversed clinical congestion and preserved approximately 80% of the flap. Venous congestion of surgically reconstructed flaps is one of the most established indications for medicinal leech therapy, where leech-mediated venous drainage and salivary anticoagulants serve a similar goal of relieving congestion and preserving tissue viability; consequently, studies of alternative pharmacologic salvage strategies are of comparative interest to the field. However, this is a single case report involving no leeches, no comparative arm, and no evaluation of hirudotherapy itself. Its relevance to ASH's domain is therefore indirect, limited to illustrating the clinical problem that leech therapy is also used to address rather than informing leech-based practice directly.

Citation

Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report.

Velasco-Bustamante J et al. · Cureus, 2026

Added to ASH library: March 18, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.